Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
| Autor: | C M B Edwards |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Agonist
medicine.medical_specialty medicine.drug_class business.industry Glucagon-like Peptide-1 Agonists General Medicine Type 2 diabetes medicine.disease Incretins Endocrinology Diabetes Mellitus Type 2 Glucagon-Like Peptide 1 Oral administration Internal medicine medicine Humans Hypoglycemic Agents business |
| Zdroj: | British Journal of Hospital Medicine. 74:198-201 |
| ISSN: | 1759-7390 1750-8460 |
| Popis: | This review discusses the rationale behind escalation of treatment for type 2 diabetes, and argues that after failure of oral medication the next logical treatment is a glucagon-like peptide-1 agonist. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|